共 50 条
- [1] ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols—Malignant Peritoneal Mesothelioma as a Model [J]. Annals of Surgical Oncology, 2023, 30 : 7858 - 7859
- [3] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma [J]. Annals of Surgical Oncology, 2021, 28 : 7118 - 7119
- [6] ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [J]. Annals of Surgical Oncology, 2018, 25 : 757 - 758
- [9] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC [J]. Annals of Surgical Oncology, 2024, 31 : 2511 - 2512
- [10] Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [J]. Annals of Surgical Oncology, 2009, 16 : 463 - 472